Elevated REG3 alpha predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy

Yang, JJ; Peng, B; Wang, L; Li, X; Li, F; Jin, XS; Jia, MY; Xu, LM; Dou, LP; Liu, DH

Dou, LP; Liu, DH (通讯作者)，Chinese PLA, Med Sch, Beijing 100853, Peoples R China.;Dou, LP; Liu, DH (通讯作者)，Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Hematol, 28 Fuxing Rd, Beijing 100853, Peoples R China.;Dou, LP (通讯作者)，Southern Med Univ, Sch Clin Med 2, Guangzhou 510515, Peoples R China.

ANNALS OF HEMATOLOGY, 2022; 101 (3): 621

Abstract

We started a single-arm, phase II, open-label, prospective clinical trial using steroids-ruxolitinib as the first-line therapy for intermediate- to hi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索